1486 related articles for article (PubMed ID: 8636289)
21. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM.
Dagogo-Jack S; Rattarasarn C; Cryer PE
Diabetes; 1994 Dec; 43(12):1426-34. PubMed ID: 7958494
[TBL] [Abstract][Full Text] [Related]
22. Effects of glycemic control on target organ responses to epinephrine in type 1 diabetes.
Aftab Guy D; Sandoval D; Richardson MA; Tate D; Davis SN
Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E258-65. PubMed ID: 15784645
[TBL] [Abstract][Full Text] [Related]
23. Intermittent hypoglycemia impairs glucose counterregulation.
Widom B; Simonson DC
Diabetes; 1992 Dec; 41(12):1597-602. PubMed ID: 1446801
[TBL] [Abstract][Full Text] [Related]
24. The effect of asymptomatic nocturnal hypoglycemia on glycemic control in diabetes mellitus.
Perriello G; De Feo P; Torlone E; Calcinaro F; Ventura MM; Basta G; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
N Engl J Med; 1988 Nov; 319(19):1233-9. PubMed ID: 3054544
[TBL] [Abstract][Full Text] [Related]
25. Influence of duration of hypoglycemia on the hormonal counterregulatory response in normal subjects.
Kerr D; MacDonald IA; Tattersall RB
J Clin Endocrinol Metab; 1989 Jun; 68(6):1118-22. PubMed ID: 2656734
[TBL] [Abstract][Full Text] [Related]
26. Pituitary function tests: comparison of ACTH and 11-deoxy-cortisol responses in the metyrapone test and with the insulin hypoglycemia test.
Steiner H; Bähr V; Exner P; Oelkers PW
Exp Clin Endocrinol; 1994; 102(1):33-8. PubMed ID: 8005206
[TBL] [Abstract][Full Text] [Related]
27. Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans.
Davis SN; Mann S; Galassetti P; Neill RA; Tate D; Ertl AC; Costa F
Diabetes; 2000 Nov; 49(11):1897-903. PubMed ID: 11078457
[TBL] [Abstract][Full Text] [Related]
28. Alteration of the counterregulatory responses to insulin-induced hypoglycemia and of cognitive function after massive weight reduction in severely obese subjects.
Guldstrand M; Ahrén B; Wredling R; Backman L; Lins PE; Adamson U
Metabolism; 2003 Jul; 52(7):900-7. PubMed ID: 12870168
[TBL] [Abstract][Full Text] [Related]
29. Physiologic hyperinsulinemia enhances counterregulatory hormone responses to hypoglycemia in IDDM.
Davis MR; Mellman M; Shamoon H
J Clin Endocrinol Metab; 1993 May; 76(5):1383-5. PubMed ID: 8496333
[TBL] [Abstract][Full Text] [Related]
30. Glucokinase activators AZD6370 and AZD1656 do not affect the central counterregulatory response to hypoglycemia in healthy males.
Norjavaara E; Ericsson H; Sjöberg F; Leonsson-Zachrisson M; Sjöstrand M; Morrow LA; Hompesch M
J Clin Endocrinol Metab; 2012 Sep; 97(9):3319-25. PubMed ID: 22723318
[TBL] [Abstract][Full Text] [Related]
31. Regulation of counterregulatory hormone secretion in man during exercise and hypoglycemia.
Sotsky MJ; Shilo S; Shamoon H
J Clin Endocrinol Metab; 1989 Jan; 68(1):9-16. PubMed ID: 2642489
[TBL] [Abstract][Full Text] [Related]
32. Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects.
Caprio S; Gerety G; Tamborlane WV; Jones T; Diamond M; Jacob R; Sherwin RS
Am J Physiol; 1991 Jun; 260(6 Pt 1):E852-8. PubMed ID: 2058661
[TBL] [Abstract][Full Text] [Related]
33. Hypoglycemia-induced autonomic failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation.
Rattarasarn C; Dagogo-Jack S; Zachwieja JJ; Cryer PE
Diabetes; 1994 Jun; 43(6):809-18. PubMed ID: 8194668
[TBL] [Abstract][Full Text] [Related]
34. Sexual dimorphism in insulin sensitivity in adolescents with insulin-dependent diabetes mellitus.
Arslanian SA; Heil BV; Becker DJ; Drash AL
J Clin Endocrinol Metab; 1991 Apr; 72(4):920-6. PubMed ID: 2005219
[TBL] [Abstract][Full Text] [Related]
35. Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests.
Nye EJ; Grice JE; Hockings GI; Strakosch CR; Crosbie GV; Walters MM; Jackson RV
J Clin Endocrinol Metab; 1999 Oct; 84(10):3648-55. PubMed ID: 10523009
[TBL] [Abstract][Full Text] [Related]
36. Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes.
Davis M; Mellman M; Friedman S; Chang CJ; Shamoon H
Am J Med; 1994 Dec; 97(6):535-42. PubMed ID: 7985713
[TBL] [Abstract][Full Text] [Related]
37. Impaired glucose disposal following mild hypoglycemia in nondiabetic and type I diabetic humans.
Davis MR; Shamoon H
Metabolism; 1992 Feb; 41(2):216-23. PubMed ID: 1736045
[TBL] [Abstract][Full Text] [Related]
38. Troglitazone amplifies counterregulatory responses to hypoglycemia in nondiabetic subjects.
Gabriely I; Wozniak R; Hawkins M; Shamoon H
J Clin Endocrinol Metab; 2001 Feb; 86(2):521-8. PubMed ID: 11158003
[TBL] [Abstract][Full Text] [Related]
39. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
[TBL] [Abstract][Full Text] [Related]
40. Counterregulatory responses to hypoglycemia in patients with glucokinase gene mutations.
Guenat E; Seematter G; Philippe J; Temler E; Jequier E; Tappy L
Diabetes Metab; 2000 Nov; 26(5):377-84. PubMed ID: 11119017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
